{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:06:52Z","timestamp":1753884412517,"version":"3.41.2"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1108","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>It has been established that survival and toxicity outcomes in some cancer types could be influenced by haemoglobin (Hb) levels. This study aims to determine if pre-treatment Hb is associated with late toxicity or survival outcomes in prostate cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Data from one Phase III randomised controlled trial and one single arm translational trial were analysed. Patients had localized prostate cancer and received \u226570\u2009Gy radiotherapy and neo-adjuvant androgen deprivation between 1997 and 2013.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>302 males were included. Median follow-up was 6.8 years for toxicity and 10.3 years for survival outcomes. Patients with Hb below the reference range were more likely to experience Grade 2\u20133 late gastrointestinal toxicity than patients with Hb within the range (p = 0.050). Neither late genitourinary toxicity, erectile function toxicity, prostate-specific antigen relapse free survival nor overall survival of patients were statistically significantly different between groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>Anaemia in prostate cancer is found in the minority of patients and is usually mild. Prostate cancer patients undergoing radiotherapy with low Hb were more likely to experience Grade 2\u20133 late gastrointestinal toxicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge:<\/jats:title>\n                  <jats:p>This study is one of the first in the published literature to investigate the role of Hb in prostate cancer toxicity and survival. We have found an association between Hb below the reference range and late GI toxicity. Consideration should be given to further investigating patients with iron deficiency anaemia to guide management options and outrule underlying GI pathology before proceeding with radiotherapy treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1259\/bjr.20190577","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T19:26:31Z","timestamp":1579202791000},"source":"Crossref","is-referenced-by-count":0,"title":["The effect of anaemia on normal tissue toxicity and survival outcomes in prostate cancer treated with radical radiotherapy and neo-adjuvant androgen deprivation"],"prefix":"10.1093","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4662-0104","authenticated-orcid":false,"given":"Lorna G.","family":"Keenan","sequence":"first","affiliation":[{"name":"Cancer Trials Ireland (formally All-Ireland Cooperative Oncology Research Group, ICORG) , Dublin , Ireland"},{"name":"St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazir","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary T.","family":"Dunne","sequence":"additional","affiliation":[{"name":"Cancer Trials Ireland (formally All-Ireland Cooperative Oncology Research Group, ICORG) , Dublin , Ireland"},{"name":"St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Finn","sequence":"additional","affiliation":[{"name":"St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Cancer Trials Ireland (formally All-Ireland Cooperative Oncology Research Group, ICORG) , Dublin , Ireland"},{"name":"St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"2024050215162711500_b1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia--a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2024050215162711500_b2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"2024050215162711500_b3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(03)00198-1","article-title":"The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck","volume":"68","author":"Daly","year":"2003","journal-title":"Radiother Oncol"},{"key":"2024050215162711500_b4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1055\/s-2005-870848","article-title":"The effect of haemoglobin levels on prognosis and quality of life of patients with bronchial carcinoma","volume":"130","author":"Drings","year":"2005","journal-title":"Dtsch Med Wochenschr"},{"key":"2024050215162711500_b5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02716547","article-title":"Hypoxia and anaemia in patients with cancer of the uterine cervix","volume":"7","author":"Andreu-Mart\u00ednez","year":"2005","journal-title":"Clin Transl Oncol"},{"key":"2024050215162711500_b6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0360-3016(02)02896-1","article-title":"Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy","volume":"54","author":"Kapp","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2010.09.024","article-title":"The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study","volume":"98","author":"Hoff","year":"2011","journal-title":"Radiother Oncol"},{"key":"2024050215162711500_b8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3109\/0284186X.2011.592650","article-title":"Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials","volume":"50","author":"Hoff","year":"2011","journal-title":"Acta Oncol"},{"key":"2024050215162711500_b9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2024050215162711500_b10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00441-016-2461-3","article-title":"Hypoxia in tissue repair and fibrosis","volume":"365","author":"Darby","year":"2016","journal-title":"Cell Tissue Res"},{"key":"2024050215162711500_b11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2005.10.005","article-title":"Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation","volume":"77","author":"Christie","year":"2005","journal-title":"Radiother Oncol"},{"key":"2024050215162711500_b12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/030089160509100108","article-title":"Hemoglobin levels and acute radiotherapy-induced toxicity","volume":"91","author":"Esc\u00f3 Bar\u00f3n","year":"2005","journal-title":"Tumori"},{"key":"2024050215162711500_b13","article-title":"Haemoglobin levels may predict toxicities in patients on pelvic chemoradiation for carcinoma of the cervix-experience of a regional cancer centre","volume":"8","author":"Gangopadhyay","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"2024050215162711500_b14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijrobp.2009.12.006","article-title":"Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy","volume":"79","author":"Kollmeier","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijrobp.2010.04.065","article-title":"A randomized trial (Irish clinical oncology Research Group 97-01) comparing short versus protracted neoadjuvant hormonal therapy before radiotherapy for localized prostate cancer","volume":"81","author":"Armstrong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5-6","key":"2024050215162711500_b17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/prca.201300004","article-title":"Development of a label-free LC-MS\/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy","volume":"7","author":"Morrissey","year":"2013","journal-title":"Proteomics Clin Appl"},{"key":"2024050215162711500_b18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2024050215162711500_b19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ajh.20260","article-title":"Predictive risk factors and prevalence of malignancy in patients with iron deficiency anemia in Taiwan","volume":"78","author":"Ho","year":"2005","journal-title":"Am J Hematol"},{"key":"2024050215162711500_b21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1445-5994.2012.02724.x","article-title":"Evaluation of iron deficiency anaemia in tertiary hospital settings: room for improvement?","volume":"42","author":"Khadem","year":"2012","journal-title":"Intern Med J"},{"key":"2024050215162711500_b22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2006.12.015","article-title":"Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial","volume":"68","author":"van der Wielen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0360-3016(01)01504-8","article-title":"Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?","volume":"50","author":"Chen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0090-4295(99)00032-1","article-title":"Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation","volume":"54","author":"Turner","year":"1999","journal-title":"Urology"},{"key":"2024050215162711500_b27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1200\/JCO.1997.15.1.223","article-title":"Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study","volume":"15","author":"Beard","year":"1997","journal-title":"J Clin Oncol"},{"key":"2024050215162711500_b28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11547-015-0586-1","article-title":"Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy","volume":"121","author":"Franceschini","year":"2016","journal-title":"Radiol Med"},{"key":"2024050215162711500_b29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00066-016-0999-3","article-title":"Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10\/94","volume":"192","author":"Ghadjar","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"2024050215162711500_b30","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1007\/s12032-012-0247-3","article-title":"Swedish lung cancer radiation Study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer","volume":"29","author":"Holgersson","year":"2012","journal-title":"Med Oncol"},{"key":"2024050215162711500_b31","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/codi.13342","article-title":"Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors","volume":"18","author":"Kapacee","year":"2016","journal-title":"Colorectal Dis"},{"key":"2024050215162711500_b32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1515\/raon-2015-0015","article-title":"The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin","volume":"50","author":"Oblak","year":"2016","journal-title":"Radiol Oncol"},{"key":"2024050215162711500_b33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF03038495","article-title":"Survival of exclusively irradiated patients with NSCLC. significance of pretherapeutic hemoglobin level","volume":"174","author":"Wilhelm","year":"1998","journal-title":"Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft"},{"key":"2024050215162711500_b34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ijrobp.2006.02.008","article-title":"Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy","volume":"65","author":"Pai","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215162711500_b35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0360-3016(03)00821-6","article-title":"The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +\/- neoadjuvant androgen deprivation","volume":"58","author":"Parker","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/93\/1108\/20190577\/57374521\/bjr.20190577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/93\/1108\/20190577\/57374521\/bjr.20190577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T16:27:56Z","timestamp":1714667276000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20190577\/7448974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":35,"journal-issue":{"issue":"1108","published-online":{"date-parts":[[2020,1,29]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20190577","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"type":"print","value":"0007-1285"},{"type":"electronic","value":"1748-880X"}],"subject":[],"published-other":{"date-parts":[[2020,4,1]]},"published":{"date-parts":[[2020,1,29]]},"article-number":"20190577"}}